Low Blood Sugar on a GLP-1: Who Needs to Worry

The short answer is that it depends entirely on what else you take, and for most people reading this it is not the explanation for how they feel.

What the label says

The Wegovy label’s hypoglycemia section says that patients with diabetes mellitus taking the medication in combination with insulin or an insulin secretagogue may have an increased risk of hypoglycemia, including severe hypoglycemia. That qualifier matters and is worth noticing: the labeled concern attaches to people with diabetes on those other medications rather than to everyone.

It advises considering a reduction in the dose of the insulin or secretagogue when starting, and that all patients be informed of the risk and taught the symptoms.

The trial numbers put that in proportion. Among people with type 2 diabetes in the weight-reduction trials, clinically significant hypoglycemia was reported in 6.2% on the medication against 2.5% on placebo, with one severe episode requiring assistance on the medication and none on placebo. Rates were higher in people also taking a sulfonylurea.

Note the population in that figure: people with type 2 diabetes. That is the group the risk concentrates in.

The three groups who should pay attention

1. Anyone taking insulin. This is the clearest case. The label advises considering a reduction in insulin dose when starting, which is a prescriber decision and not one to make yourself. If you take insulin and are starting a GLP-1, the clinician who manages your insulin needs to be involved before your first injection, not after.

2. Anyone taking a sulfonylurea or similar insulin secretagogue. These medications push your body to release insulin whether or not you have eaten. Add a medication that reduces how much you eat and the arithmetic gets uncomfortable. The label names higher rates with sulfonylurea use specifically, and the same point applies: doses may need adjusting, by the person who prescribes them.

3. Anyone with a history of bariatric surgery. The label names this as a risk factor and notes that people with that history had more events of serious hypoglycemia on the medication than on placebo. Low blood sugar after bariatric surgery is a recognized issue in its own right, and this adds to it. Tell your prescriber about the surgery.

If none of those is you, and particularly if you do not have diabetes, the risk from the GLP-1 alone is low. That does not mean nothing can make you feel shaky, which is the next section.

What the shakiness usually is

Most people who search this do not have hypoglycemia. Three other explanations are far more common and they are distinguishable.

Dehydration. Extremely common on these medications, particularly after doses and during any gastrointestinal upset. It produces lightheadedness, weakness and a racing heart, which is close enough to low blood sugar to be confused with it. Reduced urination alongside it points here.

Blood pressure falling as you lose weight. If you take medication for blood pressure, the dose that was right at your starting weight may be too much at your current one. Dizziness on standing is the signature, and the fix is a medication review rather than sugar.

Simply not eating enough. Feeling weak, shaky and unable to concentrate when you have eaten very little all day is not a mystery, and it is not hypoglycemia in the clinical sense. Watch for the cluster: persistent fatigue that sleep does not fix, feeling cold when others are comfortable, hair shedding, dizziness on standing, losing strength, weight coming off faster than intended.

That last one is the commonest answer in this whole article, and the response is eating on a schedule rather than treating a blood sugar problem you do not have.

Know the symptoms anyway

Whether or not you are in a risk group, these are worth recognizing: shakiness, sweating, a racing or pounding heart, sudden hunger, irritability or anxiety, confusion or difficulty concentrating, blurred vision, weakness, tingling around the mouth.

Severe hypoglycemia means confusion severe enough that someone cannot help themselves, seizures, or loss of consciousness. That is an emergency and needs emergency services.

If you are in one of the three groups above, ask your prescriber whether you should have a glucose meter, what to keep with you for treating a low, and what your threshold is for calling. Ask before you need it.

Consider this scenario: someone with type 2 diabetes on both insulin and a sulfonylurea starts a GLP-1 through a telehealth service. Nobody adjusts either diabetes medication, because the service prescribing the GLP-1 does not manage them and the clinician who does is not told. Their appetite drops substantially in the first fortnight while both drugs keep working at their old doses. The combination was foreseeable and the fix was a conversation before the first injection.

What to do if you are in a risk group

Get the two prescribers talking, or at least both informed. If your GLP-1 comes from a telehealth service and your diabetes medication from elsewhere, you are the only person who can connect them. Do it.

Do not adjust insulin or a sulfonylurea yourself, in either direction. That belongs to whoever prescribes it.

Expect more attention during titration. The days after each increase are when appetite drops most, which is when the mismatch between what you eat and what your other medication assumes is largest. Our guide on dose escalation covers how the steps are meant to work, and our guide on the tirzepatide starting dose covers the early progression. If you take insulin, a slower ramp is a reasonable thing to ask for.

Tell someone you live or work with what the symptoms look like, if you are at real risk.

Sick days need their own plan. If you cannot eat and you are still taking a medication that lowers glucose, that is a situation to have instructions for in advance rather than to work out while unwell.

Contact your provider if

You take insulin or a sulfonylurea and nobody has reviewed those doses since you started, you have had symptoms suggesting a low, you feel shaky or dizzy regularly, you have had bariatric surgery and your prescriber does not know, or you are unsure whether you should be monitoring. That last one is worth a call by itself.

Our guide on getting the most out of your GLP-1 treatment covers what ongoing monitoring should look like, and if you take anything else for blood sugar, the monitoring is the part that matters most.

The short version

If you take insulin, a sulfonylurea, or have had bariatric surgery, this is a real risk and the doses of those other medications may need adjusting by whoever prescribes them, ideally before your first GLP-1 injection. If none of that applies and you do not have diabetes, the risk from the medication alone is low. And if you feel shaky and dizzy, the likeliest explanations are dehydration, a blood pressure medication that is now too strong for your weight, or simply not eating enough, all of which have different answers from low blood sugar.

If you want a provider who will check what else you take before the first dose rather than after, TrimRx includes ongoing provider access alongside treatment.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.